Portal de Periódicos da CAPES

Data and interpretation: economic evaluations in transfusion medicine, P art 4

2013; Wiley; Volume: 53; Issue: 10 Linguagem: Italiano

10.1111/trf.12185

1537-2995

Seema Kacker, Kevin D. Frick, Aaron A.R. Tobian,

Healthcare cost, quality, practices

TransfusionVolume 53, Issue 10 p. 2130-2133 CLINICAL RESEARCH FOCUS #37 Data and interpretation: economic evaluations in transfusion medicine, Part 4 Seema Kacker, Seema Kacker Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorKevin D. Frick, Kevin D. Frick Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorAaron A.R. Tobian, Corresponding Author Aaron A.R. Tobian Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandAddress reprint requests to: Aaron A.R. Tobian, MD, PhD, Transfusion Medicine Division, Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Carnegie 437, Baltimore, MD 21287; e-mail: [email protected].Search for more papers by this author Seema Kacker, Seema Kacker Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorKevin D. Frick, Kevin D. Frick Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandSearch for more papers by this authorAaron A.R. Tobian, Corresponding Author Aaron A.R. Tobian Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MarylandAddress reprint requests to: Aaron A.R. Tobian, MD, PhD, Transfusion Medicine Division, Department of Pathology, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Carnegie 437, Baltimore, MD 21287; e-mail: [email protected].Search for more papers by this author First published: 08 April 2013 https://doi.org/10.1111/trf.12185Citations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Kacker S, Frick KD, Tobian A. Costs of transfusion: economic evaluations in transfusion medicine, Part 1. Transfusion 2013; 53: 1383– 1385 2 Kacker S, Frick KD, Tobian A. Establishing a framework: economic evaluations in transfusion medicine, Part 2. Transfusion 2013; 53: 1634– 1636 3 Kacker S, Frick KD, Tobian A. Constructing a model: economic evaluations in transfusion medicine, Part 3. Transfusion 2013; 53: 1885– 1887 4 Drummond MF. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford; New York: Oxford University Press; 2005. 5 Jain R, Grabner M, Onukwugha E. Sensitivity analysis in cost-effectiveness studies: from guidelines to practice. Pharmacoeconomics 2011; 29: 297- 314. 6 Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479- 500. 7 Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ 1999; 319: 635- 638. 8 Custer B. Economic analyses of blood safety and transfusion medicine interventions: a systematic review. Transfus Med Rev 2004; 18: 127- 143. 9 AuBuchon JP, Birkmeyer JD, Busch MP. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion 1997; 37: 45- 51. 10 Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721- 729. 11 Blumberg N, Heal JM. Mortality risks, costs, and decision making in transfusion medicine. Am J Clin Pathol 2000; 114: 934- 937. Citing Literature Volume53, Issue10October 2013Pages 2130-2133 ReferencesRelatedInformation